Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hoft

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Cellular Microbiology|June 3, 2011
Optimizing vaccine developmentDaniel F Hoft, Vladimir Brusic, Isaac G Sakala
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2020
Influenza Challenge Models: Ready for Prime Time?David I Bernstein, Robert L Atmar, Daniel F Hoft
Frontiers in Immunology|April 14, 2023
Impact of BCG vaccination on the repertoire of human γδ T cell receptorsMei Xia, Azra Blazevic, Andrew Fiore-Gartland, et al.
Frontiers in Immunology|March 7, 2019
BCG Vaccination Induces <i>M. avium</i> and <i>M. abscessus</i> Cross-Protective ImmunityGetahun Abate, Fahreta Hamzabegovic, Christopher S Eickhoff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunityCharles T Spencer, Getahun Abate, Azra Blazevic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustionNicole L Sullivan, Christopher S Eickhoff, John Sagartz, et al.
Microbes and Infection|September 25, 2002
Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infectionAnita R Schnapp, Christopher S Eickhoff, Julio Scharfstein, et al.
Preventive Medicine Reports|July 13, 2023
Lower risk for COVID-19 hospitalization among patients in the United States with past vaccinations for herpes zoster and tetanus, diphtheria and pertussisJoanne Salas, John E Morley, Daniel F Hoft, et al.
Memorias Do Instituto Oswaldo Cruz|September 14, 2010
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infectionChristopher S Eickhoff, Olivia K Giddings, Nobuko Yoshida, et al.
Tuberculosis (Edinburgh, Scotland)|June 15, 2017
Pilot studies of a human BCG challenge modelAzra Blazevic, Mei Xia, Aldin Turan, et al.
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Cellular Microbiology|June 3, 2011
Optimizing vaccine developmentDaniel F Hoft, Vladimir Brusic, Isaac G Sakala
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2020
Influenza Challenge Models: Ready for Prime Time?David I Bernstein, Robert L Atmar, Daniel F Hoft
Frontiers in Immunology|April 14, 2023
Impact of BCG vaccination on the repertoire of human γδ T cell receptorsMei Xia, Azra Blazevic, Andrew Fiore-Gartland, et al.
Frontiers in Immunology|March 7, 2019
BCG Vaccination Induces <i>M. avium</i> and <i>M. abscessus</i> Cross-Protective ImmunityGetahun Abate, Fahreta Hamzabegovic, Christopher S Eickhoff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunityCharles T Spencer, Getahun Abate, Azra Blazevic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustionNicole L Sullivan, Christopher S Eickhoff, John Sagartz, et al.
Microbes and Infection|September 25, 2002
Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infectionAnita R Schnapp, Christopher S Eickhoff, Julio Scharfstein, et al.
Preventive Medicine Reports|July 13, 2023
Lower risk for COVID-19 hospitalization among patients in the United States with past vaccinations for herpes zoster and tetanus, diphtheria and pertussisJoanne Salas, John E Morley, Daniel F Hoft, et al.
Memorias Do Instituto Oswaldo Cruz|September 14, 2010
Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infectionChristopher S Eickhoff, Olivia K Giddings, Nobuko Yoshida, et al.
Tuberculosis (Edinburgh, Scotland)|June 15, 2017
Pilot studies of a human BCG challenge modelAzra Blazevic, Mei Xia, Aldin Turan, et al.
Pageof 13